Drivelea
It is a fixed dose combination drug indicated for VIH positive patients and HLA-B*5701 negative patients, without hepatitis B virus.
Therapeutic Area
HIV + Infectology
Active Ingredient
Abacavir + Lamivudine + Dolutegravir
Line
HIV - Antivirals
Dosage forms
Dolutegravir 50mg + Abacavir 600mg + Lamivudine 300mg x 30 coated tablets.
